oral GLP-1R class B GCPR agonist

oral glucose-lowering activity observed in HV

from sensitized cell HTS of 2.8M cmpds + opt.

bioRxiv, Sep. 30, 2020

Pfizer, Cambridge, MA / Groton, CT

Structure of PF-06882961, an oral small molecule agonist of the glucagon-like peptide-1 receptor (GLP-1R)

PF-06882961 is an oral small molecule agonist of the glucagon-like peptide-1 receptor (GLP-1R). GLP-1R agonists increase the production of insulin and are highly useful in the treatment of diabetes. However,…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: